Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CSL ( (AU:CSL) ) has issued an update.
CSL Limited has announced a new dividend distribution of USD 1.62 per share for its ordinary fully paid securities. The dividend relates to the six-month period ending June 30, 2025, with an ex-date of September 9, 2025, a record date of September 10, 2025, and a payment date of October 3, 2025. This announcement underscores CSL’s commitment to providing shareholder value and reflects its stable financial performance, potentially enhancing its attractiveness to investors.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$325.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited operates in the biotechnology industry, focusing on the development and manufacturing of innovative medicines and vaccines. The company is known for its work in plasma therapies, vaccines, and other specialty pharmaceuticals, serving a global market with a strong emphasis on research and development.
YTD Price Performance: -3.21%
Average Trading Volume: 743,260
Technical Sentiment Signal: Buy
Current Market Cap: A$130.9B
For detailed information about CSL stock, go to TipRanks’ Stock Analysis page.